Citalopram
-
Subject Areas on Research
- A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder.
- A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
- Acute 5-HT reuptake blockade potentiates human amygdala reactivity.
- Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram.
- Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.
- Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
- Citalopram and quality of life in lung transplant recipients.
- Citalopram and the Curate's egg in geriatric depression.
- Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.
- Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.
- Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial.
- Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants.
- Escitalopram for the treatment of major depressive disorder in youth.
- Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial.
- Escitalopram in specific phobia: results of a placebo-controlled pilot trial.
- Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
- Escitalopram treatment of trichotillomania.
- Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
- Family history of depression and therapeutic outcome: findings from STAR*D.
- Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.
- Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
- High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.
- Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
- MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
- Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients.
- Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.
- Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers.
- Motor cortex excitability after vagus nerve stimulation in major depression.
- Pain in depression: STAR*D study findings.
- Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study.
- Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression.
- Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.
- Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
- Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
- Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study.
- Sodium channel blockade with QRS widening after an escitalopram overdose.
- TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
- The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
- The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.
- Therapy for mental stress-induced myocardial ischemia--reply.
- Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial.
- Treatment of social anxiety disorder with citalopram.
- Treatment outcome variation between depression symptom combinations in the STAR*D study.
- Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial).
- [A new quality of the therapy of anxiety and depression--escitalopram].
- fMRI tracks reductions in repetitive behaviors in autism: two case studies.
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology